Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele

DOI: 10.2147/PGPM.S146787

Full-Text   Cite this paper   Add to My Lib

Abstract:

Dear edito

Full-Text